-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HwYCqldN3qdzvR6GKWr5UXQDkjql69HCJRGU7abwROfoBn/a/38ut71xPjqr1OCp ZUlsHtWI1bcKQqHHrfxhlA== 0000874716-07-000080.txt : 20070524 0000874716-07-000080.hdr.sgml : 20070524 20070524140456 ACCESSION NUMBER: 0000874716-07-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070523 FILED AS OF DATE: 20070524 DATE AS OF CHANGE: 20070524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TONELLI QUENTIN J CENTRAL INDEX KEY: 0001184154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 07876347 BUSINESS ADDRESS: BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: C/O IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 form4tonelli_ex.xml X0202 4 2007-05-23 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184154 TONELLI QUENTIN J C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Corporate Vice President Common Stock 2007-05-23 4 M 0 2200 50.900 A 23583 D Common Stock 2007-05-23 4 S 0 2200 89.3964 D 21383 D Non-Qualified Stock Option (right to buy) 50.900 2007-05-23 4 M 0 2200 50.9000 D 2014-02-04 Common Stock 2200 2436 D The reporting person also indirectly holds 4,625 shares of common stock of IDEXX Laboratories, Inc., of which 3,575 shares are held by the Bret C. Tonelli UTMA account with Charles Schwab and 1,050 are owned by the Mary Tonelli Revocable Trust (of which Mr. Tonelli and his sister are beneficiaries). The reporting person disclaims beneficial ownership of all shares held by the Bret C. Tonelli UTMA account, and this report should not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of Section 16 or any other purpose. The reporting person reports beneficial ownership of all the shares held by the Mary Tonelli Revocable Trust, but disclaims beneficial ownership except to the extent of his pecuniary interest therein. Grant of option to buy shares of common stock exercisable in five equal annual increments, beginning on the first anniversary date (2/05/2005) of the date of grant. John B. Rogers, Attorney-in-Fact for Quentin J. Tonelli, PhD 2007-05-24 -----END PRIVACY-ENHANCED MESSAGE-----